Vor Bio Announces $55.6 Million Private Placement
Provided By GlobeNewswire
Last update: Dec 27, 2024
Intend to announce updated clinical data from Phase 1/2 VBP301 trial of VCAR33ALLO in the first half of 2025 and updated clinical data from Phase 1/2a VBP101 trial of trem-cel in combination with Mylotarg in the second half of 2025
Read more at globenewswire.com
